Better Growth Buy: Eli Lilly vs. Viking Therapeutics
Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) have garnered considerable attention over the past year due to their solid clinical progress. However, these drugmakers have also lagged the market over the trailing-12-month period. That said, there are good reasons to expect both to bounce back and perform well over the long run.
But which is a better stock to invest in today? Let's find out.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Stock
€28.25
-1.210%
Currently there is a rather positive sentiment for Viking Therapeutics Inc with 5 Buy predictions and 0 Sell predictions.
Based on the current price of 28.25 € the target price of 65 € shows a potential of 130.09% for Viking Therapeutics Inc which would more than double the current price.
